期刊文献+

混凝土梁三点弯曲负荷下声发射特性研究 被引量:12

STUDY ON THE ACOUSTIC EMISSION CHARACTERISTICS OF THE CONCRETE BEAMS UNDER THREE POINT BENDING LOAD
下载PDF
导出
摘要 研究混凝土梁受三点弯曲负荷时的声发射 ( AE)特性。结果表明在加载初期裂缝在混凝土中的形成和扩展是间歇的 ,达到临界状态后裂缝的扩展呈失稳 ;切口相对深度对混凝土梁声发射特性有着显著影响 ,切口相对深度增大 ,声发射事件突发性明显减小 ,表明其材料的脆性程度降低。 The acoustic emission (AE) characteristics of the three point bended concrete beams with notches of different relative depths were studied during the entire loading period. It was shown that the cracks formed and extended discontinuously at the inception of loading and the extension was out of stable in the state of critical loading. The relative depths of the notches affected AE characteristics obviously. The occurrence of AE events decreased greatly with the increasing of the relative depths of the notches. It meant that the brittleness of concrete decreased. The inner cracks could be located by means of AE technology.
出处 《无损检测》 2000年第3期109-111,共3页 Nondestructive Testing
关键词 声发射特性 弯曲负荷 混凝土 裂纹 Acoustic emission characteristic Bending load Concrete Crack
  • 相关文献

参考文献8

二级参考文献16

  • 1法匹拉韦说明书[OL].http://www.mhlw.go.jp/file/05-Shingikai-10901000-Kenkoukyoku-Soumuka/img-X28195440.pdf.
  • 2Furuta Y,Takahashi K,Shiraki K,et al.T-705(favipiravir)and related compounds:Novel broad-spectrum inhibitors of RNA viral infections[J].Antiviral Res,2009,82(3):95-102.
  • 3Furuta Y.Gowen B B,Takahashi K,et al.Favipiravir(T-705),a novel viral RNA polymerase inhibitor[J].Antiviral Res,2013,100(2):446-454.
  • 4Caroline A L,Powell D S,Bethel L M,et al.Broad spectrum antiviral activity of favipiravir(T-705):protection from highly lethal inhalational rrift valley fever[J].PLo S Negl Trop Dis,2014,8(4):e2790.
  • 5Furuta Y,Takahashi K,Kuno-Maekawa M,et al.Mechanism of action of T-705 against influenza virus[J].Antimicrob Agents Chemother,2005,49(3):981-986.
  • 6Guines:Preliminary Results of the Jiki Clinical Trial to Test the Efficacy of Favipiravir in Reducing Mortality in Individuals Infected by Ebola Virus in Guinea[EB/OL].http://allafrica.com/stories/201502241478.html.
  • 7Furuta Y,Hiroyuki E,Toyama Chemical Co Ltd.Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antiviral agents containing both:Japan,WO2000010569A1[P].2000-03-02.http://worldwide.espacenet.com/publication Details/biblio?CC=WO&NR=0010569A1&KC=A1&FT=D.
  • 8古田要界,江川裕之,富山化学工业株式会社.含氮杂环羧酰胺衍生物或其盐以及含有二者的抗病毒药:日本CN1313768A[P].2001-09-19.http://worldwide.espacenet.com/public ation Details/biblio?CC=CN&NR=131768A&KC=A&FT=D.
  • 9Shi F,Li Z,Kong L,et al.Synthesis and crystal structure of6-fluoro-3-hydroxypyrazine-2-carboxamide[J].Drug Discov Ther,2014,8(3):117-120.
  • 10吕新军(编译),Huang C,Wang Y,Li X.武汉市新型冠状病毒感染患者的临床特征[J].中华实验和临床病毒学杂志,2020,34(1):42-42. 被引量:2547

共引文献1486

同被引文献158

引证文献12

二级引证文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部